BALLATORE, ZELMIRA
 Distribuzione geografica
Continente #
NA - Nord America 686
EU - Europa 372
AS - Asia 146
AF - Africa 27
SA - Sud America 18
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.250
Nazione #
US - Stati Uniti d'America 686
IT - Italia 88
UA - Ucraina 55
SE - Svezia 53
IE - Irlanda 43
RU - Federazione Russa 41
SG - Singapore 40
CN - Cina 33
DE - Germania 30
TR - Turchia 28
HK - Hong Kong 23
DK - Danimarca 21
CI - Costa d'Avorio 20
BR - Brasile 17
FI - Finlandia 15
GB - Regno Unito 12
KR - Corea 11
IN - India 9
FR - Francia 6
MA - Marocco 6
BE - Belgio 4
AT - Austria 3
EU - Europa 1
ID - Indonesia 1
JP - Giappone 1
PE - Perù 1
PL - Polonia 1
ZA - Sudafrica 1
Totale 1.250
Città #
Chandler 116
Ashburn 59
Jacksonville 58
Dublin 43
Boardman 41
New York 40
Fairfield 36
Wilmington 29
Singapore 26
Woodbridge 26
Seattle 24
Hong Kong 23
Centro 22
Abidjan 20
Houston 19
Ancona 18
Des Moines 18
Ann Arbor 16
Cambridge 16
Lawrence 14
Princeton 14
San Mateo 12
Turin 11
San Diego 8
Pune 7
Los Angeles 6
Guangzhou 5
Washington 5
Beijing 4
Brussels 4
Helsinki 4
Moscow 4
Porto 4
The Dalles 4
Cantu 3
Chiaravalle 3
Dallas 3
London 3
Prescot 3
São Paulo 3
Vienna 3
Wuxi 3
Chennai 2
Kilburn 2
Marche 2
Munich 2
Phoenix 2
Rome 2
Salvador 2
Segrate 2
Tolentino 2
Arequipa 1
Atlanta 1
Bari 1
Birmingham 1
Blumenau 1
Brandenburg 1
Capelinha 1
Cerquilho 1
Chicago 1
Dalian 1
Divinópolis 1
Duque de Caxias 1
Falconara Marittima 1
Fayetteville 1
Guarulhos 1
Istanbul 1
Jequié 1
Jiaxing 1
Johannesburg 1
Manaus 1
Mauá 1
Montegiorgio 1
Norwalk 1
Nuremberg 1
Osimo 1
Piedade 1
Porto Alegre 1
Prudnik 1
Rio Branco 1
San Francisco 1
Sano 1
Santa Clara 1
Secaucus 1
Shanghai 1
Shaoxing 1
Suzhou 1
Wuhan 1
Zhuhai 1
Zibo 1
Totale 837
Nome #
Thymic neoplasms: an update on the use of chemotherapy and new targeted therapies. A literature review. 123
Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy 116
Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients 113
Irinotecan-Induced Transient Dysarthria: Case Series and Updated Literature Review 95
Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma 90
Phosphorylated mTOR is associated to androgen receptor expression in early triple-negative breast cancer 86
Paclitaxel and Bevacizumab in First Line-Treatment Patients with HER-2 Negative Advanced Breast Cancer: Who could Benefit? 82
Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex 81
Everolimus and exemestane in long survival hormone receptor positive male breast cancer: case report 79
IMPACT OF VEGF, VEGFR, PDGFR, HIF AND ERCC1 GENE POLYMORPHISMS ON THYMIC MALIGNANCIES OUTCOME 79
Patient and caregiver needs in oncology. An Italian survey 79
Hedgehog (Hh) Signaling is a Predictor of Clinical Outcome for Advanced Non-Small Cell Lung Cancer (NSCLC). 73
The impact of lifestyle interventions in high‐risk early breast cancer patients: A modeling approach from a single institution experience 70
Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type 61
Cancer patient perspective in the arena of COVID-19 pandemic 47
Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD) 22
Totale 1.296
Categoria #
all - tutte 7.286
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.286


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202023 0 0 0 0 0 0 0 0 0 0 3 20
2020/2021210 12 22 24 1 25 16 18 16 16 31 20 9
2021/2022108 9 15 2 4 0 9 7 5 7 17 10 23
2022/2023320 22 42 15 26 24 54 0 6 74 2 45 10
2023/2024193 25 6 8 21 27 65 3 4 2 6 1 25
2024/2025224 51 26 8 2 18 9 25 4 46 14 21 0
Totale 1.296